Our results also revealed overexpression of pRb/E2F1, cyclin A, Cdk2, and cyclin D1 proteins in BPH-1 cells, whereas 6SL treatment downregulated the expression of cell cycle regulatory proteins, consistent with inhibition of pRb/E2F1 expression. The gene discussed is RB1; the disease is benign prostatic hyperplasia.